LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announces the launch of a new product that will assist pharmaceutical scientists in estimating the effects of physiological fluids on the solubility of drug-like molecules.
